Evidence map›Paper›PMID 42622273›Full record

ArticleThe journal of physical chemistry. B2026

Quantifying the Sequence-Dependent Kinetic Protection of Reduced Heme in Peptide Amphiphile Nanofibers.

Blake Campbell, Abigail Rogers, Nathan A Hernandez-Martinez, Subas Dangi, Lee A Solomon

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Blake CampbellDepartment of Biology, George Mason University, Fairfax, Virginia22030, United States.
Abigail RogersDepartment of Biology, George Mason University, Fairfax, Virginia22030, United States.
Nathan A Hernandez-MartinezDepartment of Biology, George Mason University, Fairfax, Virginia22030, United States.
Subas DangiDepartment of Chemistry, George Mason University, Fairfax, Virginia22030, United States.ORCID 0000-0002-4161-2834
Lee A SolomonDepartment of Chemistry, George Mason University, Fairfax, Virginia22030, United States.ORCID 0000-0003-1471-9510

Funding

George Mason University NANational Science Foundation (NSF) BMAT 2041751
6 · The paper itself

Abstract

Replicating the protective dielectric environment of natural cytochromes within synthetic assemblies is essential for the development of air-stable bioelectronics. We report a redox-triggered "supramolecular gate" in self-assembled peptide amphiphile (PA) nanofibers that provide significant kinetic protection to ferrous heme B under aerobic conditions. By systematically varying side-chain steric bulk and hydrophobicity in a series of c16HHX4K3 PAs, we identified a phenylalanine variant (c16HHFL3K3) that extends the ferrous lifetime to over five seconds. Using a comprehensive multicomponent kinetic model, we resolve an initial protection phase in the c16HHFL3K3 variant that is absent in smaller side-chain controls like alanine. Potentiometric titrations revealed massive redox hysteresis (ΔEm up to 305 mV), representing the mechanistic barrier required for the transition to a "locked" state. Circular dichroism spectra support this transition as a cooperative increase in superhelical twisting upon reduction. These findings establish sequence-specific design rules for stimulus-responsive "insulation" in peptide-based materials, enabling the protection of reactive redox centers in atmospheric environments.

Indexed as

HemeNanofibersPeptidesSurface-Active AgentsAmino Acid SequenceHydrophobic and Hydrophilic InteractionsKineticsOxidation-ReductionHemePeptidesSurface-Active Agents

Identifiers

PMID42622273
PMCPMC13501876

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.